Artrya Limited ASX: AYA Share Price & Review

AYA Overview

AYA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Weak

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About AYA

Website

N/A

Telephone

61.8.6478.7816

Address

1257 Hay Street West Perth, Western Australia (WA) 6005

Description

Artrya Ltd. develops the Salix suite of products to address coronary artery disease (CAD). It uses artificial intelligence (AI) to improve the detection and management of coronary artery disease. The company was founded by John Windsor Barrington and John Konstantopoulos on January 24, 2018 and is headquartered in West Perth, Australia.

AYA Price Chart

Key Stats

Market Cap

AU$243.51M

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.25 - 2.25

Trade Value (12mth)

AU$59,954.00

1 week

6.15%

1 month

111.22%

YTD

233.87%

1 year

652.73%

All time high

2.25

Key Fundamentals

EPS 3 yr Growth

-31.40%

EBITDA Margin

Operating Cashflow

-$14m

Free Cash Flow Return

-71.80%

ROIC

-84.10%

Interest Coverage

-720.30

Quick Ratio

8.30

Other Data

Shares on Issue (Fully Dilluted)

104m

HALO Sector

Technology

Next Company Report Date

27-Aug-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AYA Announcements

Latest Announcements

Date	Announcements
01 September 25	Company Presentation × Company Presentation
26 August 25	Change in substantial holding × Change in substantial holding
26 August 25	Issue of Shares on Exercise of Performance Rights × Issue of Shares on Exercise of Performance Rights
26 August 25	Application for quotation of securities - AYA × Application for quotation of securities - AYA
25 August 25	SAPPHIRE Study Update - Piedmont Healthcare to participate × SAPPHIRE Study Update - Piedmont Healthcare to participate
25 August 25	Issue of Shares on Exercise of Options × Issue of Shares on Exercise of Options
25 August 25	Application for quotation of securities - AYA × Application for quotation of securities - AYA
21 August 25	FDA clearance of Salix Coronary Plaque module × FDA clearance of Salix Coronary Plaque module
21 August 25	Issue of Securities × Issue of Securities
21 August 25	Application for quotation of securities - AYA × Application for quotation of securities - AYA
21 August 25	Notification regarding unquoted securities - AYA × Notification regarding unquoted securities - AYA
20 August 25	Appendix 4E and Annual Financial Statements × Appendix 4E and Annual Financial Statements
08 August 25	Presentation - 19th Annual Bioshares Investor Conference × Presentation - 19th Annual Bioshares Investor Conference
04 August 25	Application for quotation of securities - AYA × Application for quotation of securities - AYA
28 July 25	Quarterly Activities/Appendix 4C Cash Flow Report × Quarterly Activities/Appendix 4C Cash Flow Report
28 July 25	Application for quotation of securities - AYA × Application for quotation of securities - AYA
21 July 25	Application for quotation of securities - AYA × Application for quotation of securities - AYA
14 July 25	Application for quotation of securities - AYA × Application for quotation of securities - AYA
10 July 25	AYA Signs US$0.6m Five Year Contract with Tanner Health × AYA Signs US$0.6m Five Year Contract with Tanner Health
03 July 25	Notification of cessation of securities - AYA × Notification of cessation of securities - AYA
01 July 25	Artrya Leadership Transition × Artrya Leadership Transition
01 July 25	Issue of Shares on Exercise of Options × Issue of Shares on Exercise of Options
01 July 25	Application for quotation of securities - AYA × Application for quotation of securities - AYA
01 July 25	Notification of cessation of securities - AYA × Notification of cessation of securities - AYA
20 June 25	Issue of Shares on Exercise of Incentive Securities × Issue of Shares on Exercise of Incentive Securities

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Falling Divs over next 2

Values and Recommendations

Key Stats

Consensus Score

Recommendation

EPS 1 month Change

Quality Yield

Falling Divs over next 2

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AYA Shortsell

Frequently Asked Questions

What is the current share price of Artrya Limited (AYA:ASX)?

The current share price of Artrya Limited (AYA:ASX) is AU$2.26.

What is the 52-week high share price for Artrya Limited (AYA:ASX)?

The 52-week high share price for Artrya Limited (AYA:ASX) is AU$2.25.

What is the 52-week low share price for Artrya Limited (AYA:ASX)?

The 52-week low share price for Artrya Limited (AYA:ASX)? is AU$0.25.

What is the dividend yield for Artrya Limited (AYA:ASX)?

Artrya Limited (AYA:ASX) does not pay a dividend.

What was Artrya Limited (AYA:ASX) last dividend payment?

Artrya Limited (AYA:ASX) does not pay a dividend.

What is the franking level for Artrya Limited (AYA:ASX)?

Artrya Limited (AYA:ASX) has a franking level of 0.0%.

In which sector is Artrya Limited (AYA:ASX) classified?

Artrya Limited (AYA:ASX) is classified in the Technology.

The current P/E ratio for Artrya Limited (AYA:ASX) is .

What is the current share price of Artrya Limited (AYA:ASX)?

The current share price of Artrya Limited (AYA:ASX) is AU$2.26.

What is the 52-week high share price for Artrya Limited (AYA:ASX)?

The 52-week high share price for Artrya Limited (AYA:ASX) is AU$2.25.

What is the 52-week low share price for Artrya Limited (AYA:ASX)?

The 52-week low share price for Artrya Limited (AYA:ASX)? is AU$0.25.

What is the dividend yield for Artrya Limited (AYA:ASX)?

Artrya Limited (AYA:ASX) does not pay a dividend.

What was Artrya Limited (AYA:ASX) last dividend payment?

Artrya Limited (AYA:ASX) does not pay a dividend.

What is the franking level for Artrya Limited (AYA:ASX)?

Artrya Limited (AYA:ASX) has a franking level of 0.0%.

In which sector is Artrya Limited (AYA:ASX) classified?

Artrya Limited (AYA:ASX) is classified in the Technology.

The current P/E ratio for Artrya Limited (AYA:ASX) is .

Company

Important

Get the latest insights and hot tips delivered right to your inbox

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.

AYA · ASX

Artrya Limited (ASX:AYA)

AU$2.26

AYA Overview

AYA Health Scores

About AYA

AYA Price Chart

Key Stats

AU$243.51M

N/A

N/A

Dividends Overview

N/A

N/A

N/A

Market Data

Key Fundamentals

Other Data

AYA Announcements

Latest Announcements

Company Presentation

Change in substantial holding

Issue of Shares on Exercise of Performance Rights

Application for quotation of securities - AYA

SAPPHIRE Study Update - Piedmont Healthcare to participate

Issue of Shares on Exercise of Options

Application for quotation of securities - AYA

FDA clearance of Salix Coronary Plaque module

Issue of Securities

Application for quotation of securities - AYA

Notification regarding unquoted securities - AYA

Appendix 4E and Annual Financial Statements

Presentation - 19th Annual Bioshares Investor Conference

Application for quotation of securities - AYA

Quarterly Activities/Appendix 4C Cash Flow Report

Application for quotation of securities - AYA

Application for quotation of securities - AYA

Application for quotation of securities - AYA

AYA Signs US$0.6m Five Year Contract with Tanner Health

Notification of cessation of securities - AYA

Artrya Leadership Transition

Issue of Shares on Exercise of Options

Application for quotation of securities - AYA

Notification of cessation of securities - AYA

Issue of Shares on Exercise of Incentive Securities

Dividends

Key Stats

N/A

N/A

N/A

N/A

Values and Recommendations

Key Stats

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

0.00%

0

N/A

N/A

N/A

N/A

Discover Short-sellingOpportunities

AYA Shortsell

Related Companies

Frequently Asked Questions

Company

Company

Important

Discover
Short-selling
Opportunities